Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs

Abstract

BackgroundThere is uncertainty about the contribution of specific pharmacological properties to the efficacy of antidepressants.AimsTo assess whether specific pharmacological characteristics of alternative antidepressants resulted in altered efficacy compared to that of selective serotonin reuptake inhibitors in the treatment of major depression.MethodMeta-regression analysis of randomised trials that compare treatment with a selective serotonin reuptake inhibitor and an alternative antidepressant.ResultsOne-hundred-and-five randomised trials were included. None of the factors identified a priori predicted a statistically significant improvement in outcome across the trials.ConclusionsThis analysis does not provide evidence that antidepressants acting at more than one pharmacological site differ in efficacy from drugs selective for serotonin reuptake in the treatment of major depression.